MAPT and Alzheimer disease: The FACEmemory is an app‐based cognitive assessment tool that focuses on face recognition memory. Participants are shown a series of faces and must recognize and recall them after a delay. The tool also correlates memory performance with AD‐related biomarkers, such as Aβ42 and tau proteins. Outputs include memory scores related to cognitive performance, and it is used to detect early cognitive decline, particularly related to AD.